| CAS No. | 13991-36-1 |
| Molecular Formula | C4H5BrO2 |
| Molecular Weight | 164.99 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Compared with other compounds in its class, the molecular weight of 164.99 g/mol gives Neratinib Impurity 8 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
Neratinib Impurity 8 (CAS 13991-36-1) is a certified pharmaceutical impurity reference standard with the molecular formula C4H5BrO2 and a molecular weight of 164.99 g/mol.
Owing to a carboxylic acid group, a hydroxyl group, an ether linkage, bromine substitution, Neratinib Impurity 8 is typically white to off-white crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 164.99 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Neratinib Impurity 8 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C4H5BrO2 |
| Molecular Weight | 164.99 g/mol |
| Purity | >95% |
| Storage | Store at 2-8°C, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 1960 |
| Halogen Content | Br-containing |